About
Mariette van der Velden-Roesink is a Dutch life sciences investor and founding partner of Curie Capital, an early-stage healthcare venture firm focused on biotech, pharma, diagnostics, and medtech. Before launching Curie Capital in 2018, she was Senior Investment Manager Life Sciences & Health at Brabant Development Agency (BOM), where she managed a portfolio of up to 13 companies and represented BOM as shareholder and board member. Her public track record centers on seed and Series A investing in Dutch and European life sciences companies including TargED, Citryll, Sirius Medical, Cleara Biotech, Laigo Bio, and Avidicure.
Areas of interest
life sciencesbiotechtherapeuticsmedical technologydiagnosticshealthcare investingseed investingseries a investingimmunologyoncologythrombosissenescencesurgical oncology